Conor McNamara
Stock Analyst at RBC Capital
(0.88)
# 3,203
Out of 4,667 analysts
99
Total ratings
19.44%
Success rate
-13.84%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $17 → $13 | $4.81 | +170.27% | 6 | Nov 8, 2024 | |
| HOLX Hologic | Maintains: Sector Perform | $86 → $89 | $78.68 | +13.12% | 8 | Nov 5, 2024 | |
| ILMN Illumina | Maintains: Outperform | $252 → $254 | $133.37 | +90.45% | 12 | Nov 5, 2024 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $446 → $469 | $322.92 | +45.24% | 8 | Oct 31, 2024 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $446 → $469 | $334.85 | +40.06% | 8 | Oct 31, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $767 → $718 | $509.59 | +40.90% | 13 | Oct 24, 2024 | |
| DHR Danaher | Maintains: Outperform | $333 → $311 | $231.32 | +34.45% | 7 | Oct 23, 2024 | |
| RGEN Repligen | Reiterates: Outperform | $205 | $139.07 | +47.41% | 9 | Sep 26, 2024 | |
| AVTR Avantor | Reiterates: Outperform | $34 | $20.20 | +68.36% | 5 | Sep 26, 2024 | |
| QDEL QuidelOrtho | Reiterates: Outperform | $61 | $37.88 | +61.03% | 10 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $7 | $3.89 | +79.95% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $72 → $70 | $70.17 | -0.24% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.18 | +120.13% | 4 | Aug 7, 2024 |
Maravai LifeSciences Holdings
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $4.81
Upside: +170.27%
Hologic
Nov 5, 2024
Maintains: Sector Perform
Price Target: $86 → $89
Current: $78.68
Upside: +13.12%
Illumina
Nov 5, 2024
Maintains: Outperform
Price Target: $252 → $254
Current: $133.37
Upside: +90.45%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Outperform
Price Target: $446 → $469
Current: $322.92
Upside: +45.24%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Outperform
Price Target: $446 → $469
Current: $334.85
Upside: +40.06%
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $767 → $718
Current: $509.59
Upside: +40.90%
Danaher
Oct 23, 2024
Maintains: Outperform
Price Target: $333 → $311
Current: $231.32
Upside: +34.45%
Repligen
Sep 26, 2024
Reiterates: Outperform
Price Target: $205
Current: $139.07
Upside: +47.41%
Avantor
Sep 26, 2024
Reiterates: Outperform
Price Target: $34
Current: $20.20
Upside: +68.36%
QuidelOrtho
Aug 16, 2024
Reiterates: Outperform
Price Target: $61
Current: $37.88
Upside: +61.03%
Aug 16, 2024
Reiterates: Outperform
Price Target: $7
Current: $3.89
Upside: +79.95%
Aug 8, 2024
Maintains: Sector Perform
Price Target: $72 → $70
Current: $70.17
Upside: -0.24%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.18
Upside: +120.13%